Description
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Product Unit Size | Cost | Quantity | Stock |
---|
CNX-774 inhibits Bruton’s tyrosine kinase (BTK) and displays potential anticancer and immunosuppressive activities.
Cas No. | 1202759-32-7 |
---|---|
Purity | ≥98% |
Formula | C26H22FN7O3 |
Formula Wt. | 499.50 |
Chemical Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
IUPAC Name | 4-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide |
Synonym | CNX774 |
Solubility | DMSO 100 mg/mL (200.2 mM) Ethanol 2 mg/mL (4.0 mM) Water Insoluble |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Akinleye A, Chen Y, Mukhi N, et al. Ibrutinib and novel BTK inhibitors in clinical development. J Hematol Oncol. 2013 Aug 19;6:59. PMID: 23958373.
FIASMA, mAChR, 5-HT2/3/6/7, α1/2-adrenergic an...
Carotenoid terpene pigment found in various pla...
Benzimidazole; microtubule polymerization inhib...
HIV protease inhibitor.
Triterpene saponin found in Bupleurum.
VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
Synephrine is an endogenous alkaloid.
Endogenous peptide hormone, involved in water h...
Viral RNA polymerase inhibitor.
M4 mAChR agonist, 5-HT1A partial agonist, M1/2/...
Hydroxycinnamic aicd, verbascoside metabolite, ...
Recombinant HCV antigen fragment.
Endogenous pteridine metabolite of GTP.
σ2 agonist.
EGFR and PDGFR inhibitor
Protease inhibitor.
Endogenous quaternary ammonium, required for fa...
SERM.
Endogenous antimicrobial peptide, binds bacteri...
Synthesis intermediate